10/05/2024  15:41:37 Diferencia +0.15 Volumen Bid15:42:21 Ask15:42:26 Capitalización de mecado Dividendo A. P/E Ratio
50.95EUR +0.30% 60,777
Volumen de negocios: 1.12 millones
50.90Volumen de oferta: 262 50.95Tamaño/ Volumen/ Formato de Ask: 402 10.51 mil millonesEUR 2.35% 26.94

Descripción de negocio

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases.
 

Consejo de gestión & Consejo de supervisión

CEO
Robert Koremans
Consejo de gestión
Andrea Recordati, Giampiero Mazza, Guido Guidi, Joanna Le Couilliard, Michaela Castelli, Piergiorgio Peluso, Cathrin Petty, Giorgio De Palma, Elisa Corghi, Luigi La Corte, Kim Stratton
Consejo de supervisión
Antonio Santi, Andrea Balelli, Ezio Simonelli, Livia Amidani Aliberti, Patrizia Oriundi Paleologo, Emiliano Nitti , Marco Antonio Viganò
 

Datos de la empresa

Nombre: Recordati S.p.A.
Dirección: via M. Civitali 1,I-20148 Milano
Teléfono: +39-02-48787-1
Fax: +39-02-40073-747
E-mail: -
Internet: www.recordati.com/
Industria: Healthcare
Sector: Pharmaceutical Industry
Subsector: Pharmaceuticals
Fin del año financiero: 31/12
Acciones de libre circulación: 46.40%
Fecha de OPI: 01/01/1984

Relación con inversores

Nombre: Marianne Tatschke
IR teléfono: -
IR-fax: +39-02-48787-225
IR e-mail: inver@recordati.it

Calendario de la empresa

CW 21 | 20/05/2024 Ex-Dividend
CW 21 | 21/05/2024 Record Date
CW 21 | 22/05/2024 Dividend Payment
CW 31 | 30/07/2024 Interim Report 2nd Quarter/6 Months
CW 45 | 08/11/2024 Interim Report 3rd Quarter/9 Months
 

Accionistas mayoritarios

CVC Capital Partners
 
51.80%
Otros
 
48.20%